• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

葡萄糖脑苷脂酶基因沉默增强帕金森病相关α-突触核蛋白突变体A53T的聚集并影响运动活性。

Silencing of Glucocerebrosidase Gene in Enhances the Aggregation of Parkinson's Disease Associated α-Synuclein Mutant A53T and Affects Locomotor Activity.

作者信息

Abul Khair Salema B, Dhanushkodi Nisha R, Ardah Mustafa T, Chen Wenfeng, Yang Yufeng, Haque M Emdadul

机构信息

Department of Biochemistry, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.

Institute of Life Sciences, Fuzhou University, Fuzhou, China.

出版信息

Front Neurosci. 2018 Feb 16;12:81. doi: 10.3389/fnins.2018.00081. eCollection 2018.

DOI:10.3389/fnins.2018.00081
PMID:29503608
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5820349/
Abstract

Mutations in glucocerebrosidase (GBA), a lysosomal enzyme are the most common genetic risk factor for developing Parkinson's disease (PD). We studied how reduced GCase activity affects α-synuclein (α-syn) and its mutants (A30P and A53T) aggregation, neurodegeneration, sleep and locomotor behavior in a fly model of PD. We developed with GBA gene knockdown (RNAi) (with reduced GCase activity) that simultaneously expresses either wildtype (WT) or mutants such as A30P or A53T α-syn. Western blot and confocal microscopy were performed to study the α-syn aggregation and neurodegeneration in these flies. We also studied the sleep and locomotor activity of those flies using activity monitor (DAM) system. Western blot analysis showed that GBA RNAi A53T α-syn flies (30 days old) had an increased level of Triton insoluble synuclein (that corresponds to α-syn aggregates) compared to corresponding A53T flies without GBA RNAi (control), while mRNA expression of α-syn remained unchanged. Confocal imaging of whole brain staining of 30 days old showed a statistically significant decrease in neuron numbers in PPL1 cluster in flies expressing α-syn WT, A30P and A53T in the presence GBA RNAi compared to corresponding control. Staining with conformation specific antibody for α-syn aggregates showed an increased number of neurons staining for α-syn aggregates in A53T fly brain with GBA RNAi compared to control A53T flies, thus confirming our protein analysis finding that under decreased GBA enzyme activity, mutant A53T aggregates more than the control A53T without GBA silencing. Sleep analysis revealed decreased total activity in GBA silenced flies expressing mutant A53T compared to both A53T control flies and GBA RNAi flies without synuclein expression. In A53T flies with reduced GCase activity, there is increased α-syn aggregation and dopamine (DA) neuronal loss. This study demonstrates that reduced GCase activity both in the context of heterozygous GBA1 mutation associated with PD and in old age, contribute to increased aggregation of mutant α-syn A53T and exacerbates the phenotype in a fly model of PD.

摘要

溶酶体酶葡萄糖脑苷脂酶(GBA)的突变是帕金森病(PD)最常见的遗传风险因素。我们研究了在PD果蝇模型中,GCase活性降低如何影响α-突触核蛋白(α-syn)及其突变体(A30P和A53T)的聚集、神经退行性变、睡眠和运动行为。我们构建了GBA基因敲低(RNAi)(GCase活性降低)且同时表达野生型(WT)或A30P或A53T等突变体α-syn的果蝇。通过蛋白质免疫印迹法和共聚焦显微镜来研究这些果蝇中α-syn的聚集和神经退行性变。我们还使用活动监测器(DAM)系统研究了这些果蝇的睡眠和运动活性。蛋白质免疫印迹分析表明,与未进行GBA RNAi的相应A53T果蝇(对照)相比,GBA RNAi A53Tα-syn果蝇(30日龄)中Triton不溶性突触核蛋白(对应于α-syn聚集体)水平升高,而α-syn的mRNA表达保持不变。对30日龄果蝇全脑染色的共聚焦成像显示,与相应对照相比,在存在GBA RNAi的情况下,表达α-syn WT、A30P和A53T的果蝇中PPL1簇的神经元数量有统计学意义的减少。用针对α-syn聚集体的构象特异性抗体染色显示,与对照A53T果蝇相比,GBA RNAi的A53T果蝇大脑中α-syn聚集体染色的神经元数量增加,从而证实了我们的蛋白质分析结果,即在GBA酶活性降低的情况下,突变体A53T比未进行GBA沉默的对照A53T聚集更多。睡眠分析显示,与A53T对照果蝇和未表达突触核蛋白的GBA RNAi果蝇相比,表达突变体A53T的GBA沉默果蝇的总活动减少。在GCase活性降低的A53T果蝇中,α-syn聚集增加且多巴胺(DA)神经元丢失。这项研究表明,在与PD相关的杂合GBA1突变背景下以及老年时,GCase活性降低均会导致突变体α-syn A53T聚集增加,并加重PD果蝇模型中的表型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1224/5820349/08eb29c26706/fnins-12-00081-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1224/5820349/7e38e0857d25/fnins-12-00081-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1224/5820349/dbd2b2d05779/fnins-12-00081-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1224/5820349/119c4854d8e1/fnins-12-00081-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1224/5820349/df416cbe8d4d/fnins-12-00081-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1224/5820349/c8178803e78a/fnins-12-00081-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1224/5820349/08eb29c26706/fnins-12-00081-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1224/5820349/7e38e0857d25/fnins-12-00081-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1224/5820349/dbd2b2d05779/fnins-12-00081-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1224/5820349/119c4854d8e1/fnins-12-00081-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1224/5820349/df416cbe8d4d/fnins-12-00081-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1224/5820349/c8178803e78a/fnins-12-00081-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1224/5820349/08eb29c26706/fnins-12-00081-g0006.jpg

相似文献

1
Silencing of Glucocerebrosidase Gene in Enhances the Aggregation of Parkinson's Disease Associated α-Synuclein Mutant A53T and Affects Locomotor Activity.葡萄糖脑苷脂酶基因沉默增强帕金森病相关α-突触核蛋白突变体A53T的聚集并影响运动活性。
Front Neurosci. 2018 Feb 16;12:81. doi: 10.3389/fnins.2018.00081. eCollection 2018.
2
ATP13A2 Gene Silencing in Drosophila Affects Autophagic Degradation of A53T Mutant α-Synuclein.在果蝇中沉默 ATP13A2 基因会影响 A53T 突变型α-突触核蛋白的自噬降解。
Int J Mol Sci. 2023 Jan 16;24(2):1775. doi: 10.3390/ijms24021775.
3
The association between lysosomal protein glucocerebrosidase and Parkinson's disease.溶酶体蛋白葡萄糖脑苷脂酶与帕金森病的关系。
Eur Rev Med Pharmacol Sci. 2013 Jan;17(2):143-51.
4
Glucocerebrosidase gene therapy prevents α-synucleinopathy of midbrain dopamine neurons.葡萄糖脑苷脂酶基因治疗可预防中脑多巴胺神经元的α-突触核蛋白病。
Neurobiol Dis. 2015 Oct;82:495-503. doi: 10.1016/j.nbd.2015.09.009. Epub 2015 Sep 25.
5
Differential interaction between iron and mutant alpha-synuclein causes distinctive Parkinsonian phenotypes in Drosophila.铁与突变型α-突触核蛋白之间的差异相互作用在果蝇中导致独特的帕金森病表型。
Biochim Biophys Acta. 2016 Apr;1862(4):518-525. doi: 10.1016/j.bbadis.2016.01.002. Epub 2016 Jan 6.
6
Glucocerebrosidase reduces the spread of protein aggregation in a Drosophila melanogaster model of neurodegeneration by regulating proteins trafficked by extracellular vesicles.葡萄糖脑苷脂酶通过调节细胞外囊泡转运的蛋白质减少神经退行性变的果蝇模型中蛋白质聚集的扩散。
PLoS Genet. 2021 Feb 4;17(2):e1008859. doi: 10.1371/journal.pgen.1008859. eCollection 2021 Feb.
7
Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons.β-葡萄糖脑苷脂酶的激活可减少帕金森病患者中脑神经元的病理性α-突触核蛋白并恢复溶酶体功能。
J Neurosci. 2016 Jul 20;36(29):7693-706. doi: 10.1523/JNEUROSCI.0628-16.2016.
8
A novel glucosylceramide synthase inhibitor attenuates alpha synuclein pathology and lysosomal dysfunction in preclinical models of synucleinopathy.一种新型的葡萄糖神经酰胺合酶抑制剂可减轻神经病变疾病的临床前模型中α-突触核蛋白病理和溶酶体功能障碍。
Neurobiol Dis. 2021 Nov;159:105507. doi: 10.1016/j.nbd.2021.105507. Epub 2021 Sep 9.
9
Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation.转 Gaucher 突变杂合子帕金森病小鼠表型增强。
Brain. 2014 Dec;137(Pt 12):3235-47. doi: 10.1093/brain/awu291. Epub 2014 Oct 27.
10
Cx3cr1-deficiency exacerbates alpha-synuclein-A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease.Cx3cr1 缺陷加剧了 α-突触核蛋白 A53T 诱导的帕金森病小鼠模型中的神经炎症和神经退行性变。
Glia. 2018 Aug;66(8):1752-1762. doi: 10.1002/glia.23338. Epub 2018 Apr 6.

引用本文的文献

1
Role and mechanism of molecular hydrogen in the treatment of Parkinson's diseases.分子氢在帕金森病治疗中的作用及机制
Front Neurosci. 2025 Apr 23;19:1576773. doi: 10.3389/fnins.2025.1576773. eCollection 2025.
2
Lysosomal dysfunction in α-synuclein pathology: molecular mechanisms and therapeutic strategies.α-突触核蛋白病中的溶酶体功能障碍:分子机制和治疗策略。
Cell Mol Life Sci. 2024 Sep 3;81(1):382. doi: 10.1007/s00018-024-05419-5.
3
Alpha Synuclein Toxicity and Non-Motor Parkinson's.α-突触核蛋白毒性与非运动性帕金森病

本文引用的文献

1
Minos-insertion mutant of the Drosophila GBA gene homologue showed abnormal phenotypes of climbing ability, sleep and life span with accumulation of hydroxy-glucocerebroside.果蝇GBA基因同源物的米诺斯插入突变体表现出攀爬能力、睡眠和寿命的异常表型,伴有羟基葡萄糖脑苷脂的积累。
Gene. 2017 May 30;614:49-55. doi: 10.1016/j.gene.2017.03.004. Epub 2017 Mar 7.
2
A New Glucocerebrosidase Chaperone Reduces α-Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism.一种新型葡萄糖脑苷脂酶伴侣可降低戈谢病和帕金森综合征患者诱导多能干细胞衍生的多巴胺能神经元中的α-突触核蛋白和糖脂水平。
J Neurosci. 2016 Jul 13;36(28):7441-52. doi: 10.1523/JNEUROSCI.0636-16.2016.
3
Cells. 2024 Jul 27;13(15):1265. doi: 10.3390/cells13151265.
4
Biochemical Fractionation of Human α-Synuclein in a Model of Synucleinopathies.人α-突触核蛋白在突触核蛋白病模型中的生化分离。
Int J Mol Sci. 2024 Mar 25;25(7):3643. doi: 10.3390/ijms25073643.
5
Animal models of Parkinson's disease: bridging the gap between disease hallmarks and research questions.帕金森病动物模型:弥合疾病特征与研究问题之间的差距。
Transl Neurodegener. 2023 Jul 19;12(1):36. doi: 10.1186/s40035-023-00368-8.
6
Functional screening of lysosomal storage disorder genes identifies modifiers of alpha-synuclein neurotoxicity.功能筛选溶酶体贮积症基因可鉴定α-突触核蛋白神经毒性的修饰因子。
PLoS Genet. 2023 May 18;19(5):e1010760. doi: 10.1371/journal.pgen.1010760. eCollection 2023 May.
7
ATP13A2 Gene Silencing in Drosophila Affects Autophagic Degradation of A53T Mutant α-Synuclein.在果蝇中沉默 ATP13A2 基因会影响 A53T 突变型α-突触核蛋白的自噬降解。
Int J Mol Sci. 2023 Jan 16;24(2):1775. doi: 10.3390/ijms24021775.
8
Exploring therapeutic potential of mitophagy modulators using models of Parkinson's disease.利用帕金森病模型探索线粒体自噬调节剂的治疗潜力。
Front Aging Neurosci. 2022 Oct 19;14:986849. doi: 10.3389/fnagi.2022.986849. eCollection 2022.
9
Studies of neurodegenerative diseases using and the development of novel approaches for their analysis.使用 研究神经退行性疾病和开发其分析的新方法。
Fly (Austin). 2022 Dec;16(1):275-298. doi: 10.1080/19336934.2022.2087484.
10
'Fly-ing' from rare to common neurodegenerative disease mechanisms.从罕见到常见神经退行性疾病机制的“飞跃”。
Trends Genet. 2022 Sep;38(9):972-984. doi: 10.1016/j.tig.2022.03.018. Epub 2022 Apr 25.
Glucocerebrosidase Deficiency in Drosophila Results in α-Synuclein-Independent Protein Aggregation and Neurodegeneration.
果蝇中的葡萄糖脑苷脂酶缺乏导致α-突触核蛋白非依赖性蛋白质聚集和神经退行性变。
PLoS Genet. 2016 Mar 28;12(3):e1005944. doi: 10.1371/journal.pgen.1005944. eCollection 2016 Mar.
4
Advances in GBA-associated Parkinson's disease--Pathology, presentation and therapies.GBA 相关帕金森病的进展——病理学、临床表现与治疗
Neurochem Int. 2016 Feb;93:6-25. doi: 10.1016/j.neuint.2015.12.004. Epub 2015 Dec 30.
5
GBA mutations are associated with Rapid Eye Movement Sleep Behavior Disorder.GBA 突变与快速眼动睡眠行为障碍有关。
Ann Clin Transl Neurol. 2015 Sep;2(9):941-5. doi: 10.1002/acn3.228. Epub 2015 Jul 31.
6
Glucocerebrosidase gene therapy prevents α-synucleinopathy of midbrain dopamine neurons.葡萄糖脑苷脂酶基因治疗可预防中脑多巴胺神经元的α-突触核蛋白病。
Neurobiol Dis. 2015 Oct;82:495-503. doi: 10.1016/j.nbd.2015.09.009. Epub 2015 Sep 25.
7
Glucocerebrosidase deficiency accelerates the accumulation of proteinase K-resistant α-synuclein and aggravates neurodegeneration in a Drosophila model of Parkinson's disease.葡萄糖脑苷脂酶缺乏会加速蛋白酶K抗性α-突触核蛋白的积累,并加重帕金森病果蝇模型中的神经退行性变。
Hum Mol Genet. 2015 Dec 1;24(23):6675-86. doi: 10.1093/hmg/ddv372. Epub 2015 Sep 11.
8
Plasma oligomeric alpha-synuclein is associated with glucocerebrosidase activity in Gaucher disease.血浆寡聚α-突触核蛋白与戈谢病中的葡萄糖脑苷脂酶活性相关。
Mov Disord. 2015 Jun;30(7):989-91. doi: 10.1002/mds.26200. Epub 2015 May 12.
9
Glucocerebrosidase and Parkinson disease: Recent advances.葡萄糖脑苷脂酶与帕金森病:最新进展
Mol Cell Neurosci. 2015 May;66(Pt A):37-42. doi: 10.1016/j.mcn.2015.03.013. Epub 2015 Mar 20.
10
Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation.转 Gaucher 突变杂合子帕金森病小鼠表型增强。
Brain. 2014 Dec;137(Pt 12):3235-47. doi: 10.1093/brain/awu291. Epub 2014 Oct 27.